↓ Skip to main content

Neurological Manifestations Related to Immune Checkpoint Inhibitors: Reverse Translational Research by Using the European Real-World Safety Data

Overview of attention for article published in Frontiers in oncology, March 2022
Altmetric Badge

Mentioned by

twitter
1 X user

Citations

dimensions_citation
11 Dimensions

Readers on

mendeley
23 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Neurological Manifestations Related to Immune Checkpoint Inhibitors: Reverse Translational Research by Using the European Real-World Safety Data
Published in
Frontiers in oncology, March 2022
DOI 10.3389/fonc.2022.824511
Pubmed ID
Authors

Rosanna Ruggiero, Barbara Stelitano, Federica Fraenza, Gabriella di Mauro, Cristina Scavone, Liberata Sportiello, Concetta Rafaniello, Raffaella Di Napoli, Romano Danesi, Marzia Del Re, Francesco Rossi, Annalisa Capuano

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 23 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 23 100%

Demographic breakdown

Readers by professional status Count As %
Student > Doctoral Student 2 9%
Lecturer 1 4%
Student > Bachelor 1 4%
Student > Ph. D. Student 1 4%
Student > Master 1 4%
Other 1 4%
Unknown 16 70%
Readers by discipline Count As %
Medicine and Dentistry 5 22%
Psychology 1 4%
Pharmacology, Toxicology and Pharmaceutical Science 1 4%
Unknown 16 70%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 15 March 2022.
All research outputs
#23,843,428
of 26,538,769 outputs
Outputs from Frontiers in oncology
#16,883
of 23,241 outputs
Outputs of similar age
#390,986
of 458,085 outputs
Outputs of similar age from Frontiers in oncology
#968
of 1,539 outputs
Altmetric has tracked 26,538,769 research outputs across all sources so far. This one is in the 1st percentile – i.e., 1% of other outputs scored the same or lower than it.
So far Altmetric has tracked 23,241 research outputs from this source. They receive a mean Attention Score of 3.2. This one is in the 1st percentile – i.e., 1% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 458,085 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 1,539 others from the same source and published within six weeks on either side of this one. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.